HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Treatment of testicular tumors.

Abstract
A total of 145 consecutive primary testicular tumors were treated with radiation therapy at the University of Michigan Hospital from 1955 through 1974. In patients with seminoma, the 5-year survival rate was 98% for Stage I and 88% for Stage II regardless of whether retroperitoneal lymph node dissection was done. The 5-year survival rate for embryonal carcinoma was 63% for Stage I and 66% for Stage II. For teratocarcinoma it was 100% for Stage I and 54% for Stage II. Adjuvant chemotherapy appeared to be beneficial for patients with Stage II teratocarcinoma but made no difference in patients with embryonal carcinoma.
AuthorsJ V Fayos, Y H Kim
JournalRadiology (Radiology) Vol. 128 Issue 2 Pg. 471-5 (Aug 1978) ISSN: 0033-8419 [Print] United States
PMID663263 (Publication Type: Journal Article)
Topics
  • Adolescent
  • Adult
  • Aged
  • Dysgerminoma (radiotherapy, surgery)
  • Humans
  • Male
  • Middle Aged
  • Teratoma (radiotherapy, surgery)
  • Testicular Neoplasms (radiotherapy, surgery)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: